We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.27B
AUM Growth
+$170M
Cap. Flow
-$151M
Cap. Flow %
-4.62%
Top 10 Hldgs %
19.26%
Holding
132
New
3
Increased
35
Reduced
93
Closed
1

Top Buys

Rank Stock Value
1
NOG icon
Northern Oil and Gas
NOG
+$12.9M
2
LKQ icon
LKQ Corp
LKQ
+$5.23M
3
MODV
ModivCare
MODV
+$3.07M
4
CRNC icon
Cerence
CRNC
+$2.05M
5
ROG icon
Rogers Corp
ROG
+$1.62M

Sector Composition

Rank Sector Weight
1 Industrials 25.41%
2 Technology 18.57%
3 Healthcare 16%
4 Financials 13.89%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
1
Acadia Healthcare
ACHC
$2.55B
$72.2M 2.21%
928,145
-40,767
-4% -$3.02M
HURN icon
2
Huron Consulting
HURN
$2.71B
$70.9M 2.17%
689,276
-198,944
-22% -$20.4M
AER icon
3
AerCap
AER
$23.4B
$68.5M 2.09%
921,885
-50,831
-5% -$3.36M
MMSI icon
4
Merit Medical Systems
MMSI
$4.82B
$66M 2.02%
869,484
-37,279
-4% -$2.6M
MTSI icon
5
MACOM Technology Solutions
MTSI
$17.4B
$64.1M 1.96%
690,122
-194,138
-22% -$16M
ITRI icon
6
Itron
ITRI
$4.48B
$60.8M 1.86%
804,826
-32,060
-4% -$2.09M
AEIS icon
7
Advanced Energy
AEIS
$10.1B
$58.9M 1.8%
540,892
-29,188
-5% -$2.84M
EFOR
8
Everforth Inc
EFOR
$960M
$57M 1.74%
593,152
-25,753
-4% -$2.25M
CHE icon
9
Chemed
CHE
$7.16B
$56.6M 1.73%
96,860
-4,452
-4% -$2.49M
DY icon
10
Dycom Industries
DY
$11.2B
$54.9M 1.68%
476,995
-16,353
-3% -$1.55M
AIN icon
11
Albany International
AIN
$2.09B
$51.7M 1.58%
526,060
-22,359
-4% -$1.95M
AZEK
12
DELISTED
The AZEK Co
AZEK
$47.3M 1.45%
1,236,953
-43,967
-3% -$1.37M
NBHC icon
13
National Bank Holdings
NBHC
$1.9B
$46.9M 1.43%
1,260,834
-65,395
-5% -$2.16M
ACIW icon
14
ACI Worldwide
ACIW
$6.12B
$44.7M 1.37%
1,459,807
-37,343
-2% -$935K
PBH icon
15
Prestige Consumer Healthcare
PBH
$2.47B
$44.2M 1.35%
721,352
-21,205
-3% -$1.26M
BDC icon
16
Belden
BDC
$3.97B
$43.9M 1.34%
568,486
-80,940
-12% -$6.01M
WAB icon
17
Wabtec
WAB
$49.3B
$42.5M 1.3%
334,858
-4,716
-1% -$532K
CRI icon
18
Carter's
CRI
$1.43B
$42.5M 1.3%
566,971
-15,029
-3% -$1.04M
SUM
19
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$42M 1.28%
1,090,990
-222
-0% -$7.7K
HASI icon
20
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$41.4M 1.26%
1,500,346
+68,841
+5% +$1.5M
ALE
21
DELISTED
Allete
ALE
$40.7M 1.25%
666,055
-25,175
-4% -$1.41M
EEFT icon
22
Euronet Worldwide
EEFT
$3.19B
$40.4M 1.23%
397,712
-933
-0.2% -$79.6K
HQY icon
23
HealthEquity
HQY
$8.71B
$39.7M 1.21%
599,392
-21,642
-3% -$1.5M
STAG icon
24
STAG Industrial
STAG
$7.5B
$39.2M 1.2%
998,796
-30,355
-3% -$1.08M
KN icon
25
Knowles
KN
$2.95B
$39.1M 1.2%
2,184,251
-87,449
-4% -$1.36M

Similar funds

Aristotle Capital Boston's Q4 2023 Portfolio in Review

As of Q4 2023, Aristotle Capital Boston held 132 positions worth $3.27B, up 5.5% from $3.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston withdrew a net $151M in Q4 2023, closing 1 position and reducing 93 holdings. Its most notable exit was Coherus Oncology, an estimated $8.76M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Northern Oil and Gas worth $12.6M.

  • Aristotle Capital Boston's largest Q4 2023 buy was Northern Oil and Gas: 339,979 shares worth $12.6M.
  • Aristotle Capital Boston added most to ModivCare in Q4 2023, an estimated $3.07M increase.
  • Aristotle Capital Boston's biggest Q4 2023 reduction was SP Plus Corporation, cutting an estimated $20.9M.
  • Aristotle Capital Boston fully exited Coherus Oncology in Q4 2023, selling an estimated $8.76M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $3.27B portfolio in Q4 2023.
  • Aristotle Capital Boston opened 3 new positions and closed 1 in Q4 2023.
  • Aristotle Capital Boston's portfolio value rose 5.5% quarter-over-quarter to $3.27B.

Based on Aristotle Capital Boston's 13F filing for Q4 2023, filed 14 Feb 2024.